<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05009563</url>
  </required_header>
  <id_info>
    <org_study_id>COMPOSIT Study</org_study_id>
    <nct_id>NCT05009563</nct_id>
  </id_info>
  <brief_title>COvid iMaging With POSitron Emission Tomography</brief_title>
  <acronym>COMPOSIT</acronym>
  <official_title>Evaluation of COVID-19 by Whole-body FDG-PET/CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Semmelweis University Department of Pulmonology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Semmelweis University Medical Imaging Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to study if metabolic intensity and extent according to pathologic pulmonary&#xD;
      18F-2-fluoro-2-deoxy-D-glucose (FDG)-uptake may correlate with the course of COVID-19&#xD;
      pneumonia and potentially yield prognostic value. Moreover, we aim to assess permanent&#xD;
      changes after Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, such as&#xD;
      pulmonary fibrosis and neuropsychiatric symptoms (anosmia, depression, fatigue) where&#xD;
      evaluation with FDG-positron emission tomography (PET/CT) might have an impact on further&#xD;
      patient care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several case studies confirmed increased FDG-uptake on PET scans corresponding to typical&#xD;
      pulmonary lesions on chest CT scans in patients with COVID-19 pneumonia. Furthermore,&#xD;
      increased FDG-uptake most likely caused by inflammatory changes in SARS-CoV-2 infection were&#xD;
      described in other organs, such as mediastinal lymph nodes, bone marrow, and the spleen. As&#xD;
      COVID-19 frequently presents with anosmia and on rare occasions, symptoms of encephalitis,&#xD;
      metabolic changes in the central nervous system (CNS) were also investigated by FDG-PET/CT,&#xD;
      showing hypometabolism in the olfactory gyrus and the limbic system, while hypermetabolism&#xD;
      was observed in the basal ganglia and the cerebellar vermis. Late changes in pulmonary&#xD;
      CT-morphology, most commonly interstitial thickening and crazy paving are observed,&#xD;
      suggesting permanent lung damage after SARS-CoV-2 infection in certain cases. Evaluation of&#xD;
      metabolic activity of acute and late inflammatory changes could potentially provide clinical&#xD;
      benefit as dedicated medication could be started to prevent further organ damage due to&#xD;
      prolonged inflammation.&#xD;
&#xD;
      We aim to evaluate metabolic alterations in the lung parenchyma and potential extrapulmonary&#xD;
      locations related to to COVID-19 with FDG-PET/CT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2021</start_date>
  <completion_date type="Anticipated">January 4, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 4, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>extrapulmonary increased FDG-uptake</measure>
    <time_frame>3 months</time_frame>
    <description>observation of sites with extrapulmonary hypermetabolic foci in possible conjunction with COVID-19 and brain metabolic changes, with follow-up scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total pulmonary metabolic inflammatory volume</measure>
    <time_frame>3 months</time_frame>
    <description>measurement of metabolic activity of COVID-19 pneumonia and changes on follow-up scan</description>
  </secondary_outcome>
  <other_outcome>
    <measure>cognitive status and quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>investigation of possible COVID-19-related cognitive changes and impact on quality of life, with follow-up</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronavirus Infection</condition>
  <arm_group>
    <arm_group_label>Inpatients with RT-PCR proven SARS-CoV-2 infection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inpatients with real-time reverse-transcriptase polymerase chain reaction (RT-PCR) proven SARS-CoV-2 infection of the Department of Pulmonology of Semmelweis University who will undergo whole-body FDG-PET/CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients undergoing FDG-PET/CT for oncological indication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Age- and gender-matched group of patients undergoing FDG-PET/CT for oncological indication in the same time period</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>FDG-PET/CT</intervention_name>
    <description>whole-body F-18-fluoro-deoxy-glucose positron emission tomography/computed tomography</description>
    <arm_group_label>Inpatients with RT-PCR proven SARS-CoV-2 infection</arm_group_label>
    <arm_group_label>patients undergoing FDG-PET/CT for oncological indication</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inpatients with RT-PCR proven SARS-CoV-2 infection of the Department of Pulmonology of&#xD;
             Semmelweis University&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age&lt;40 years for men and &lt;45 years for women&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Clinically unstable patients&#xD;
&#xD;
          -  Patients in need of mechanical ventilation support&#xD;
&#xD;
          -  Patients with known malignant disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pál Maurovich Horvat, MD PhD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University Medical Imaging Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pál Maurovich Horvat, MD PhD MPH</last_name>
    <phone>+361459-1500</phone>
    <phone_ext>61812</phone_ext>
    <email>titkarsag.okk@med.semmelweis-univ.hu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Semmelweis University Medical Imaging Centre</name>
      <address>
        <city>Budapest</city>
        <state>Pest</state>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pál Maurovich Horvat, MD PhD MPH</last_name>
      <phone>+361459-1500</phone>
      <phone_ext>61812</phone_ext>
      <email>okk.titkarsag@med.semmelweis-univ.hu</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Qin C, Liu F, Yen TC, Lan X. (18)F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1281-1286. doi: 10.1007/s00259-020-04734-w. Epub 2020 Feb 22.</citation>
    <PMID>32088847</PMID>
  </reference>
  <reference>
    <citation>Zou S, Zhu X. FDG PET/CT of COVID-19. Radiology. 2020 Aug;296(2):E118. doi: 10.1148/radiol.2020200770. Epub 2020 Mar 6.</citation>
    <PMID>32142399</PMID>
  </reference>
  <reference>
    <citation>Liu C, Zhou J, Xia L, Cheng X, Lu D. 18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient With Dynamic Clinical Characteristics in Different Period. Clin Nucl Med. 2020 Jun;45(6):495-496. doi: 10.1097/RLU.0000000000003068.</citation>
    <PMID>32332319</PMID>
  </reference>
  <reference>
    <citation>Cabrera Villegas A, Romero Robles LG, Boulvard Chollet XLE, Albornoz Almada MC, Mangas Losada M, Garrastachu P, Cañete Sánchez FM, Ramírez Lasanta R, Delgado Bolton RC. [(18)F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):786-793. doi: 10.1007/s00259-020-04979-5. Epub 2020 Sep 16.</citation>
    <PMID>32936372</PMID>
  </reference>
  <reference>
    <citation>Dietz M, Chironi G, Claessens YE, Farhad RL, Rouquette I, Serrano B, Nataf V, Hugonnet F, Paulmier B, Berthier F, Keita-Perse O, Giammarile F, Perrin C, Faraggi M; MONACOVID Group. COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):260-268. doi: 10.1007/s00259-020-04968-8. Epub 2020 Jul 25.</citation>
    <PMID>32712702</PMID>
  </reference>
  <reference>
    <citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, Raoult D. (18)F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):592-595. doi: 10.1007/s00259-020-04973-x. Epub 2020 Jul 30.</citation>
    <PMID>32728799</PMID>
  </reference>
  <reference>
    <citation>Grimaldi S, Lagarde S, Harlé JR, Boucraut J, Guedj E. Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from (18)F-FDG PET Imaging and Neuronal Autoantibodies. J Nucl Med. 2020 Dec;61(12):1726-1729. doi: 10.2967/jnumed.120.249292. Epub 2020 Jul 24.</citation>
    <PMID>32709734</PMID>
  </reference>
  <reference>
    <citation>Yu M, Liu Y, Xu D, Zhang R, Lan L, Xu H. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia. Korean J Radiol. 2020 Jun;21(6):746-755. doi: 10.3348/kjr.2020.0215.</citation>
    <PMID>32410413</PMID>
  </reference>
  <reference>
    <citation>Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, Shi H, Zhou M. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020 Aug;296(2):E55-E64. doi: 10.1148/radiol.2020200843. Epub 2020 Mar 19.</citation>
    <PMID>32191587</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 16, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID19</keyword>
  <keyword>PET-CT</keyword>
  <keyword>brain</keyword>
  <keyword>lung</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

